Patents by Inventor Joseph P. Haar, Jr.

Joseph P. Haar, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9415044
    Abstract: An improved process for the N-alkylation of tertiary morphinan alkaloid bases to form the corresponding quaternary morphinan alkaloid derivatives.
    Type: Grant
    Filed: December 12, 2014
    Date of Patent: August 16, 2016
    Assignee: Mallinckrodt LLC
    Inventors: Peter X. Wang, Robert E. Halvachs, Kevin R. Roesch, Henry J. Buehler, Joseph P. Haar, Jr., Gary L. Cantrell
  • Publication number: 20150099773
    Abstract: An improved process for the N-alkylation of tertiary morphinan alkaloid bases to form the corresponding quaternary morphinan alkaloid derivatives.
    Type: Application
    Filed: December 12, 2014
    Publication date: April 9, 2015
    Inventors: Peter X. Wang, Robert E. Halvachs, Kevin R. Roesch, Henry J. Buehler, Joseph P. Haar, Jr., Gary L. Cantrell
  • Patent number: 8946433
    Abstract: The present disclosure generally related to an improved process for the preparation of various piperidine derivatives. More particularly, the present disclosure related to an improved process for preparing sufentanil base (1) and related compounds, which advantageously utilizes more cost effective and/or less hazardous reagents, including a dispersion comprising between about 50% and about 70% by weight (based on the total weight of the dispersion) of an alkali metal hydride, such as sodium hydride, as well as eliminates the need for expensive and/or time consuming purification techniques.
    Type: Grant
    Filed: September 15, 2011
    Date of Patent: February 3, 2015
    Assignee: Mallinckrodt LLC
    Inventors: Brian Orr, Joseph P. Haar, Jr., George H. Klemm, Keith G. Tomazi
  • Patent number: 8669366
    Abstract: An improved process for the N-alkylation of tertiary morphinan alkaloid bases to form the corresponding quaternary morphinan alkaloid derivatives.
    Type: Grant
    Filed: March 6, 2008
    Date of Patent: March 11, 2014
    Assignee: Mallinckrodt LLC
    Inventors: Peter X. Wang, Gary L. Cantrell, Robert E. Halvachs, Kevin R. Roesch, Henry J. Buehler, Joseph P. Haar, Jr.
  • Patent number: 8383649
    Abstract: The present invention relates to novel crystalline forms of naltrexone methobromide including hydrated and solvated forms. The invention also describes methods of preparing the various crystalline forms. The present invention also relates to pharmaceutical compositions containing crystalline forms of naltrexone methobromide, as well as methods of treating or preventing opioid induced side effects by administering the pharmaceutical compositions.
    Type: Grant
    Filed: June 25, 2008
    Date of Patent: February 26, 2013
    Assignee: Mallinckrodt LLC
    Inventors: Gary A. Nichols, Robert E. Halvachs, Gary L. Cantrell, Kevin R. Roesch, Joseph P. Haar, Jr.
  • Publication number: 20130035488
    Abstract: The present invention provides to an improved process for preparing alkaloid salts. In particular, the process comprises a stepwise addition of an acid to an alkaloid chosen from hydrocodone, codeine, and dihydrocodeine to form a flowable mixture of the alkaloid salt.
    Type: Application
    Filed: August 1, 2012
    Publication date: February 7, 2013
    Applicant: Mallinckrodt LLC
    Inventors: Bradley R. Jones, Joseph P. Haar, JR., Kevin R. Roesch, Leslie L. Vanderkolk
  • Patent number: 8283472
    Abstract: A synthetic process for the preparation of amino acid esters such as methylphenidate and analogs thereof is disclosed. The process involves reacting an amino acid such as ?-phenyl-?-(2-piperidinyl)acetic acid or an analog thereof with an alcohol such as methanol in the presence of an acid and a water sequestrant such as trimethyl orthoacetate. In some embodiments, the water sequestrant is added to the reaction mixture after an initial period of esterification and then the reaction is allowed to continue. The ?-phenyl-?-(2-piperidinyl)acetic acid methyl ester or analog thereof is then isolated from the reaction mixture. In one variation of the process, the supernatant liquid may be recycled in subsequent runs to increase yield and product purity.
    Type: Grant
    Filed: January 6, 2010
    Date of Patent: October 9, 2012
    Assignee: Mallinckrodt LLC
    Inventors: Joseph P. Haar, Jr., Carl J. Schaefer, Charles S. Kuivila
  • Publication number: 20120071659
    Abstract: The present disclosure generally related to an improved process for the preparation of various piperidine derivatives. More particularly, the present disclosure related to an improved process for preparing sufentanil base (1) and related compounds, which advantageously utilizes more cost effective and/or less hazardous reagents, including a dispersion comprising between about 50% and about 70% by weight (based on the total weight of the dispersion) of an alkali metal hydride, such as sodium hydride, as well as eliminates the need for expensive and/or time consuming purification techniques.
    Type: Application
    Filed: September 15, 2011
    Publication date: March 22, 2012
    Applicant: Mallinckrodt LLC
    Inventors: Brian ORR, Joseph P. HAAR, JR., George H. KLEMM, Keith G. TOMAZI
  • Publication number: 20110082297
    Abstract: An improved process for the N-alkylation of tertiary morphinan alkaloid bases to form the corresponding quaternary morphinan alkaloid derivatives.
    Type: Application
    Filed: March 6, 2008
    Publication date: April 7, 2011
    Inventors: Peter X. Wang, Gary L. Cantrell, Robert E. Halvachs, Kevin R. Roesch, Henry J. Buehler, Joseph P. Haar, JR.
  • Publication number: 20100324078
    Abstract: The present invention relates to novel crystalline forms of naltrexone methobromide including hydrated and solvated forms. The invention also describes methods of preparing the various crystalline forms. The present invention also relates to pharmaceutical compositions containing crystalline forms of naltrexone methobromide, as well as methods of treating or preventing opioid induced side effects by administering the pharmaceutical compositions.
    Type: Application
    Filed: June 25, 2008
    Publication date: December 23, 2010
    Inventors: Gary A. Nichols, Robert E. Halvachs, Gary L. Cantrell, Kevin R. Roesch, Joseph P. Haar, JR.
  • Publication number: 20100261906
    Abstract: The present invention provides processes for the preparation of saturated 6-keto, 3-alkoxy morphinans from unsaturated 6-hydroxy, 3-hydroxy morphinans, In particular, the invention provides processes that utilize catalytic isomerization and alkylation reactions for the preparation of saturated 6-keto, 3-alkoxy morphinans.
    Type: Application
    Filed: April 9, 2010
    Publication date: October 14, 2010
    Applicant: Mallinckrodt Inc.
    Inventors: Joseph P. Haar, JR., Kevin R. Roesch, David E. Gindelberger
  • Publication number: 20100179327
    Abstract: A synthetic process for the preparation of amino acid esters such as methylphenidate and analogs thereof is disclosed. The process involves reacting an amino acid such as ?-phenyl-?-(2-piperidinyl)acetic acid or an analog thereof with an alcohol such as methanol in the presence of an acid and a water sequestrant such as trimethyl orthoacetate. In some embodiments, the water sequestrant is added to the reaction mixture after an initial period of esterification and then the reaction is allowed to continue. The ?-phenyl-?-(2-piperidinyl)acetic acid methyl ester or analog thereof is then isolated from the reaction mixture. In one variation of the process, the supernatant liquid may be recycled in subsequent runs to increase yield and product purity.
    Type: Application
    Filed: January 6, 2010
    Publication date: July 15, 2010
    Applicant: Mallinckrodt Inc.
    Inventors: Joseph P. Haar, JR., Carl J. Schaefer, Charles S. Kuivila
  • Publication number: 20090275754
    Abstract: A process for purifying Narcotine to remove color and impurities to form Noscapine. The process includes forming an aqueous isopropanol solution with the Narcotine product wherein the isopropanol concentration of the solution is about 20% to about 70% by volume; and adjusting the pH of the solution with a strong base to a pH of about 10 to about 14, wherein impurities are removed from the Narcotine product.
    Type: Application
    Filed: March 28, 2007
    Publication date: November 5, 2009
    Inventors: Keith G. Tomazi, Leroy Love, JR., Joseph P. Haar, JR.
  • Patent number: 6225493
    Abstract: This invention relates to the purification of N-[N-(3,3-dimethylbutyl)-L-&agr;-aspartyl]-L-phenylalanine 1-methyl ester by resolving a mixture of the alpha- and beta-isomers of N-[N-(3,3-dimethylbutyl)-L-&agr;-aspartyl]-L-phenylalanine 1-methyl ester using metal ions.
    Type: Grant
    Filed: August 21, 2000
    Date of Patent: May 1, 2001
    Assignee: The Nutrasweet Company
    Inventors: Indra Prakash, Joseph P. Haar, Jr., Robert Y. Zhao
  • Patent number: 5998492
    Abstract: Disclosed are methods of producing super-absorbing polymeric networks of polyaspartates from crosslinked polysuccinimide. In one preferred aspect, polysuccinimide is first reacted with an organic crosslinking agent, preferably an organic base containing at least two primary amine groups, to form a gelled crosslinked polysuccinimide. The gelled crosslinked polysuccinimide is then base hydrolyzed to a gelled polymeric network of polyaspartate and deswollen with at least one liquid alcohol to a polymeric network of polyaspartate which demonstrates super-absorbing capability in water and in electrolyte solution. Super-absorbing polymeric networks of polyaspartates can also be produced in a single reaction vessel by sequentially crosslinking a polysuccinimide with an organic crosslinking agent in an aqueous reaction medium, optionally containing a mineral acid, and then hydrolyzing the crosslinked polysuccinimide to produce a polymeric network of polyaspartate.
    Type: Grant
    Filed: October 26, 1998
    Date of Patent: December 7, 1999
    Assignee: Donlar Corporation
    Inventors: Joseph P. Haar, Jr., Robert J. Ross
  • Patent number: 5998491
    Abstract: Super-absorbing polymeric networks of crosslinked polyaspartates are produced from crosslinked polysuccinimide. Super-absorbing polymeric networks are produced in a single reaction vessel by crosslinking polysuccinimide with at least one organic polyamine crosslinking agent in the presence of at least one nitrogenous base. The reaction is carried out in an aqueous reaction mixture to produce a polymeric network of crosslinked polyaspartate.
    Type: Grant
    Filed: January 27, 1998
    Date of Patent: December 7, 1999
    Assignee: Donlar Corporation
    Inventor: Joseph P. Haar, Jr.